Differentiated Thyroid Carcinoma: An Updated Review on: Pathogenesis, Diagnosis, and Treatment Strategies

We aim to provide a focused update on the pathogenesis, various diagnostic triaging processes, and the comprehensive treatment modalities of differentiated thyroid carcinoma. PubMed and Google Scholar databases/search engines were utilized using pertinent keywords. We prioritized recent articles from the American Thyroid Association. The diagnostic modalities span imaging features, pre-operative fine-needle aspiration, molecular and genetic analyses on these aspirates and the histopathological evaluation of resected thyroid tissue. The management protocols are variable, including surgery, radioactive iodine therapy and medical management as adjuvant treatment options. The sequence and intensity of these treatments vary and are currently dynamic. The triaging approach differs and depends on assessment of multiple risk factors of these carcinomas. This review presents recent advances in diagnostic modalities, including molecular and genetic alterations, followed by surgical, radioiodine, and targeted medical therapies. It also addresses the current standard of care and discusses the “dynamic” decision-making process. In conclusion, DTC diagnosis and management exhibited significant changes in the last two decades. Preoperative assessment by aspiration cytology is well recognized and has become standardized with evidence-based risk of malignancy assessment, and consequently triage recommendations accordingly. The spectrum of molecular and genetic signature changes of DTC is expanding and becoming available to evaluate in the preoperative evaluation phase. We review and summarize the recent consensus guidelines for surgical, radioactive iodine and medical management of DTC. We offer a discussion on the recent “dynamic risk assessment” concept as well as its relationship with the aforementioned treatment modalities.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2026-11-13
DOI
https://doi.org/10.3390/cancers18223628
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Differentiated Thyroid Carcinoma: An Updated Review on: Pathogenesis, Diagnosis, and Treatment Strategies

Kusai M. Al-Muqbel, Nidal A. Younes, Mousa Ali Al-Abbadi, Husam Abuawad et al.
3 links
Cancers
Thyroid Cancer Diagnosis and Treatment
article

Differentiated Thyroid Carcinoma: An Updated Review on: Pathogenesis, Diagnosis, and Treatment Strategies

Kusai M. Al-Muqbel, Nidal A. Younes, Mousa Ali Al-Abbadi, Husam Abuawad, Bahaa Abdelrahim, Dana Hyassat
article en

Abstract

We aim to provide a focused update on the pathogenesis, various diagnostic triaging processes, and the comprehensive treatment modalities of differentiated thyroid carcinoma. PubMed and Google Scholar databases/search engines were utilized using pertinent keywords. We prioritized recent articles from the American Thyroid Association. The diagnostic modalities span imaging features, pre-operative fine-needle aspiration, molecular and genetic analyses on these aspirates and the histopathological evaluation of resected thyroid tissue. The management protocols are variable, including surgery, radioactive iodine therapy and medical management as adjuvant treatment options. The sequence and intensity of these treatments vary and are currently dynamic. The triaging approach differs and depends on assessment of multiple risk factors of these carcinomas. This review presents recent advances in diagnostic modalities, including molecular and genetic alterations, followed by surgical, radioiodine, and targeted medical therapies. It also addresses the current standard of care and discusses the “dynamic” decision-making process. In conclusion, DTC diagnosis and management exhibited significant changes in the last two decades. Preoperative assessment by aspiration cytology is well recognized and has become standardized with evidence-based risk of malignancy assessment, and consequently triage recommendations accordingly. The spectrum of molecular and genetic signature changes of DTC is expanding and becoming available to evaluate in the preoperative evaluation phase. We review and summarize the recent consensus guidelines for surgical, radioactive iodine and medical management of DTC. We offer a discussion on the recent “dynamic risk assessment” concept as well as its relationship with the aforementioned treatment modalities.

CancersVol. 18(22)
University of Jordan (JO), Jordan University of Science and Technology (JO), National Center for Diabetes, Endocrinology and Genetic Diseases (JO)
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon